Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Circulating microRNAs from HCC patients recruited in the Ph3 RESORCE trial

ABSTRACT: Circulating microRNAs from HCC patients recruited in the Ph3 RESORCE trial

PROVIDER: PRJNA488486 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Circulating microRNAs from HCC patients recruited in the Ph3 RESORCE trial

Project description:Micro RNAs are deregulated in a variety of human cancers.In this study we analayzed baseline expression levels of circulating human micro RNAs from patients of the Ph 3 RESORCE trial for predictive value of overall survival and time to progression.

2019-01-01 | GSE119221 | GEO

NanoString nCounter Human HCC expression analysis

Project description:Archival tumor tissues from HCC patients recruited in the Ph 3 RESORCE trial were analysed with the pan Cancer immune profiling panel

2019-01-01 | GSE119220 | GEO

Actinomyces sp. ph3

Project description:Actinomyces sp. ph3 Genome sequencing and assembly

| PRJEA82081 | ENA

Pseudomonas savastanoi strain:Ph3

Project description:Pseudomonas savastanoi strain:Ph3 Genome sequencing and assembly

| PRJNA388575 | ENA

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, identify cirrhotic patients with HCC

Project description:In this study we investigated the expression of circulating miRNAs in patients with cirrhosis, early and advanced HCC on cirrhosis by using a two-steps approach. The study was designed as a two phase epidemiological study with a hypothesis generating step conducted by means of microarray assay, specifically aimed at discovering a genome-wide aberrantly regulated circulating miRNA panel able to differentiate cirrhotic (N. 11) from HCC (N. 12) patients followed by a validation phase performed on an independent series of 118 consecutive cirrhotic patients.

2016-11-14 | E-MTAB-3895 | biostudies-arrayexpress

Sphingobium xenophagum strain:PH3-15

Project description:Sphingobium xenophagum strain:PH3-15 Genome sequencing and assembly

| PRJNA600023 | ENA

Trial

Project description:Trial Trial

| PRJEB7892 | ENA

Identification of p53-regulated microRNAs in Hapatocellular Carcinoma (HCC).

Project description:p53 suppresses tumor progression and metastasis by regulating a large set of genes and microRNAs. By profiling 92 primary hepatocellular carcinomas (HCCs) and 9 HCC cell lines, we found that p53 upregulates microRNAs including miR-200 and miR-192 family members. By sequencing TP53 in 92 HCC samples, we classified the 92 samples into two groups (wt and mut). We also classified 9 HCC cell lines by testing p21 expression after DNA-damage mediated p53 activation. We then profiled microRNA expression in 92 HCC tissue samples and 9 HCC celll lines to identify p53-regulated microRNAs.

2011-05-11 | E-GEOD-28661 | biostudies-arrayexpress

RNA-Seq of synovial tissue biopsies from individuals with rheumatoid arthritis from the R4RA randomised clinical trial

Project description:Transcriptomic profiles of synovial biopsies of rheumatoid arthritis (RA) patients who were recruited into the R4RA randomised clinical trial. Patients were randomised to treatment with rituximab or tocilizumab. All patients fulfilled the 2010 ACR/EULAR classification criteria for RA and were eligible for treatment with rituximab therapy according to UK NICE guidelines, i.e. failing or intolerant to csDMARD therapy and at least one biologic therapy (excluding trial IMPs) were recruited when fulfilling the trial inclusion/exclusion criteria. For the full study protocol and baseline patient characteristics see Humby et al (2021) The Lancet 397(10271): 305-17. PMID: 33485455.

2022-04-26 | E-MTAB-11611 | biostudies-arrayexpress

RNA sequencing data of TCam-2, 2102EP, JAR, JEG-3, NCCIT, and MPAF fibroblast cells treated with palbociclib and H2O pH3 as solvent control

Project description:RNA sequencing data of TCam-2, 2102EP, JAR, JEG-3, NCCIT, and MPAF fibroblast cells treated with palbociclib and H2O pH3 as solvent control

2021-12-15 | GSE190792 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data